ProCE Banner Activity

MM34: Update on Investigational Antiviral Therapies for COVID-19

Multimedia
In this presentation, Dr. Sharon Lewin reviews recent data on investigational therapies for COVID-19, including TMPRSS2 inhibitors, CRISPR-Cas13, and interferon lambda.

Released: March 18, 2021

Expiration: March 17, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Educational grant provided by

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Sharon R. Lewin, AO, FRACP, PhD, FAA, FAHMS

Director, Doherty Institute
Melbourne Laureate Professor
Director, Cumming Global Centre for Pandemic Therapeutics
Head, Department of Infectious Diseases
The University of Melbourne
Melbourne, Australia